Priorities for CMV vaccine development-Reference-Cited by-同舟云学术

Priorities for CMV vaccine development

Published:2013-12 Issue:1 Volume:32 Page:4-10
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Krause Philip R.,Bialek Stephanie R.,Boppana Suresh B.,Griffiths Paul D.,Laughlin Catherine A.,Ljungman Per,Mocarski Edward S.,Pass Robert F.,Read Jennifer S.,Schleiss Mark R.,Plotkin Stanley A.

Funder

National Vaccine Program Office

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference55 articles.

1. New vaccine development: establishing priorities,1985

2. Editors committee to study priorities for Vaccine Development Division of Health Promotion and Disease Prevention Institute of Medicine;Kathleen,2000

3. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee;Arvin;Clin Infect Dis,2004

4. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection;Dollard;Rev Med Virol,2007

5. Cytomegalovirus seroprevalence in the United States: the National Health and Nutrition Examination Surveys, 1988–2004;Bate;Clin Infect Dis,2010

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burden of Congenital CMV Infection: A Narrative Review and Implications for Public Health Interventions;Viruses;2024-08-17

2. A UL26-PIAS1 complex antagonizes anti-viral gene expression during Human Cytomegalovirus infection;PLOS Pathogens;2024-05-20

3. Vaccine value profile for cytomegalovirus;Vaccine;2023-11

4. Human cytomegalovirus pUL97 upregulates SOCS3 expression via transcription factor RFX7 in neural progenitor cells;PLOS Pathogens;2023-02-08

5. Cytomegalovirus Vaccines;Plotkin's Vaccines;2023